698ACHILLES THERAPEUTICS ADS
CUSIP 00449L102 · Yahoo Finance ↗ · Google Finance ↗
Achilles Therapeutics Ads (698) has 3 institutional holders in Filings Flow’s 13F database, together reporting 36.0K shares worth $53,336 as of Q1 2026. The largest reported holders are Trium Capital LLP, Rhumbline Advisers, and Gamma Investing LLC.
Institutional Holders
3
Q1 2026
Reported Value
$53,336
Ticker
698
Quarters Tracked
6
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Trium Capital LLP$142M AUM | 0.03% | $45,514 | 30.8K | Q1 2026OLDER |
| GAMMA Investing LLC$2.7B AUM | 0.00% | $1,193 | 806 | Q2 2026 |
| RHUMBLINE ADVISERS$116.9B AUM | 0.00% | $6,629 | 4.5K | Q1 2026OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.